Riskpilot← Back to searchSign inGet full accessHorsted Institute ApS
APSActiveCVR 42339091Wilders Plads 8AMedical specialists activities · NACE 8622Est. 20212 employeesHorstedinstitute.com
Revenue 2025
DKK 1,5M
+95% vs 2024
EBITDA margin
49.0%
+2432% vs 2024
Equity ratio
64.1%
Financial strength
Net profit 2025
DKK 489K
+1229% vs 2024
| Revenue | DKK 1,5M | +95% |
| EBITDA | DKK 714K | +2432% |
| Net profit | DKK 489K | +1229% |
| Total assets | DKK 810K | +19% |
| Equity | DKK 519K | +1618% |
| Employees | 2 | — |
Legal name
Horsted Institute ApS
CVR number
42339091
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
15. april 2021
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen eller den samlede bestyrelse
Company purpose
Virksomhedens formål er at levere lægefaglige ydelser samt hermed beslægtet virksomhed efter direktionens skøn
Address
Wilders Plads 8A
Phone
+4531321434
Email
info@horstedinstitute.com
Website
Horstedinstitute.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 633 | 803 | 1.053 | 746 | 1.457 |
| Staff expenses | -416 | -448 | -587 | -718 | -743 |
| EBITDA | 217 | 355 | 466 | 28 | 714 |
| Depreciation & amort. | -0 | -0 | -24 | -71 | -71 |
| EBIT | 217 | 355 | 442 | -43 | 643 |
| Net financials | -3 | -4 | 1 | -10 | -12 |
| Profit before tax | 214 | 351 | 443 | -53 | 631 |
| Tax | 47 | 79 | 98 | -9 | 142 |
| Net profit | 167 | 272 | 345 | -43 | 489 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 566 | 507 | 1.024 | 678 | 810 |
| Equity | 207 | 329 | 674 | 30 | 519 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 359 | 179 | 320 | 627 | 266 |
| Total debt | 359 | 179 | 320 | 627 | 266 |
EBITDA margin
49.0%
This company
15.8%
Market median
+210% vs market
20212025
Equity ratio
64.1%
This company
38.2%
Market median
+68% vs market
20212025
Return on equity
94.2%
This company
18.4%
Market median
+412% vs market
20212025
Net profit margin
33.5%
This company
8.1%
Market median
+314% vs market
20212025
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20212025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TI Management | Management | 2021 |
| Former (1) | ||
SF Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T. Horsted Holding ApS
Horsted Institute ApS Board members of Horsted Institute ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tina Ingrid Horsted | Management | 0 companies |
| Suzanne Flagstad | Chief Executive Officer | 0 companies |
| Mogens Trygve Lied Flagstad | Chairman | 0 companies |